Nasr A, Sami R, Ibrahim N, Darwish D
Trulicity, however, is approved for treatment of type 2 diabetes in adults and children ages 10 and older, while Ozempic is approved for treatment of type 2 diabetes in adults only
Beyond drugs, a growing number of companies are targeting the behavioral side of weight loss, combining these approaches with GLP-1 treatments to improve outcomes
Key Takeaways GLP-1 medications are powerful metabolic therapiesnot casual prescriptions Baseline lab testing improves safety, personalization, and outcomes Skipping labs introduces avoidable risks Not all providers follow the same clinical standards Patients should prioritize medically supervised care Metos Perspective: A Clinical-First Approach At Meto, the position is straightforward: GLP-1 therapy should begin with data, not assumptions
Neuropsychopharmacology Review, 35(2), 156 - 170
Delta sleep-inducing peptide (DSIP), as a neuropeptide, plays an important role in regulating sleep, mood, and stress responses